112 related articles for article (PubMed ID: 7084127)
1. Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes.
Takeda R; Tatami R; Ueda K; Haba T; Kawato M; Nakabayashi H; Mabuchi H
Endokrinologie; 1982 Feb; 79(1):140-8. PubMed ID: 7084127
[TBL] [Abstract][Full Text] [Related]
2. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
3. The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood.
Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA
Pediatrics; 1977 Apr; 59(4):513-25. PubMed ID: 191790
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.
Lam KS; Chan MK; Yeung RT
Q J Med; 1986 May; 59(229):513-21. PubMed ID: 3763814
[TBL] [Abstract][Full Text] [Related]
5. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
[TBL] [Abstract][Full Text] [Related]
6. [Lipoproteins, post-heparin lipoprotein lipase and hepatic triglyceride lipase in patients with and without severe hyperlipemia caused by alcoholism].
Breier C; Lisch HJ; Braunsteiner H
Acta Med Austriaca; 1985; 12(1):25-9. PubMed ID: 4013622
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
8. Effects of growth hormone on lipoprotein lipase and hepatic lipase.
Oscarsson J; Ottosson M; Edén S
J Endocrinol Invest; 1999; 22(5 Suppl):2-9. PubMed ID: 10442563
[TBL] [Abstract][Full Text] [Related]
9. Low postheparin plasma hepatic lipase activity in familial type IIa hyperlipoproteinemia.
Nikkilä EA; Huttunen JK; Ehnholm C
Ann Clin Res; 1976 Feb; 8(1):63-7. PubMed ID: 180867
[TBL] [Abstract][Full Text] [Related]
10. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
Weinstock PH; Bisgaier CL; Aalto-Setälä K; Radner H; Ramakrishnan R; Levak-Frank S; Essenburg AD; Zechner R; Breslow JL
J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein metabolism in postmenopausal and oophorectomized women.
Wakatsuki A; Sagara Y
Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of a high-sucrose diet on plasma lipid, lipoprotein cholesterol, tissue lipoprotein lipase and hepatic triglyceride lipase in rats.
Saku K; Okamoto T; Takeda Y; Jimi S; Zhang B; Bai H; Liu R; Arakawa K
Artery; 1996; 22(1):36-48. PubMed ID: 8781709
[TBL] [Abstract][Full Text] [Related]
13. [Very low density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women].
Berg G; Halperín H; Siseles N; Wikinski R
Medicina (B Aires); 1996; 56(5 Pt 1):479-86. PubMed ID: 9239883
[TBL] [Abstract][Full Text] [Related]
14. Typing of hyperlipoproteinemia in an Israel hospital.
Eisenberg S
Isr J Med Sci; 1976 Nov; 12(11):1261-8. PubMed ID: 1017927
[TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
16. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
Valdemarsson S; Hansson P; Hedner P; Nilsson-Ehle P
Acta Endocrinol (Copenh); 1983 Sep; 104(1):50-6. PubMed ID: 6624364
[TBL] [Abstract][Full Text] [Related]
17. Decreased activities of lipoprotein lipase and hepatic triglyceride lipase in patients with gout.
Tsutsumi Z; Yamamoto T; Moriwaki Y; Takahashi S; Hada T
Metabolism; 2001 Aug; 50(8):952-4. PubMed ID: 11474484
[TBL] [Abstract][Full Text] [Related]
18. The effect of atorvastatin on serum lipoproteins in acromegaly.
Mishra M; Durrington P; Mackness M; Siddals KW; Kaushal K; Davies R; Gibson M; Ray DW
Clin Endocrinol (Oxf); 2005 Jun; 62(6):650-5. PubMed ID: 15943824
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
[TBL] [Abstract][Full Text] [Related]
20. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]